A NOVEL CLASS OF GALECTIN-1 INHIBITORS FOR PROSTATE CANCER THERAPY

$915,156FY2019Defense Health AgencyDOD

University Of California, Davis

Investigators

View source on USAspending →

A NOVEL CLASS OF GALECTIN-1 INHIBITORS FOR PROSTATE CANCER THERAPY · GrantIndex